Condition · Sleep
Insomnia / Sleep Quality
00
Background biology
Insomnia involves hyperarousal, circadian timing, sleep homeostasis, behaviour and medical or psychological contributors.
01
Evidence-ranked peptides
| Peptide | Use | Evidence |
|---|---|---|
| DSIP DSIP is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials. | Insomnia / Sleep Quality insufficient | Human3/5 Animal0/5 Safety3/5 3 verified refs |
02
Current standard management
conventional medicineCognitive behavioural therapy for insomnia is first-line, with licensed medicines used selectively according to clinical need.
Medical disclaimer —Standard-of-care information is educational only. Do not change or start treatment based on Atlas content. Always consult a qualified clinician for personal medical decisions.
04
Linked mechanisms
biological pathways discussed for this condition- Sleep homeostasis and neuropeptide signallinglimited
05
Research gaps
what we don't know yet- ·Modern DSIP replication
- ·Validated receptor or pathway
- ·Larger controlled trials
- ·Long-term safety
03
Community observations
No approved community reports for this condition yet. Submit one.
Clinician discussion
Questions you can ask a qualified clinician
- What are the established evidence-based options for this condition?
- What monitoring is appropriate before considering any experimental intervention?
- What long-term safety data exists for peptide-based approaches?
- Are there licensed medicines relevant to my situation?
↳
Explore further
from the knowledge graphPeptides that touch this
Mechanisms in play